CorFlow Therapeutics Secures FDA Approval for MOCA-II Pivotal Study of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics Secures FDA Approval for MOCA-II Pivotal Study of Innovative Heart Attack Treatment Technology

A pioneer in cardiac treatment for microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has granted its technology an Investigational Use Exemption (IDE), allowing the pivotal clinical trial to begin in U.S. hospitals. CorFlow will now…

Read MoreCorFlow Therapeutics Secures FDA Approval for MOCA-II Pivotal Study of Innovative Heart Attack Treatment Technology
ICON and Employees Honored as Industry Leaders in Clinical Research, Innovation, and Sustainability

ICON and Employees Honored as Industry Leaders in Clinical Research, Innovation, and Sustainability

A world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and…

Read MoreICON and Employees Honored as Industry Leaders in Clinical Research, Innovation, and Sustainability
CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics AG  a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial…

Read MoreCorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology
Modivcare Honors DAB Transport for Compassionate Service and Community Health Impact

Modivcare Honors DAB Transport for Compassionate Service and Community Health Impact

A technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, proudly recognizes DAB Transport’s outstanding commitment to service central Georgia with compassion and flexibility. Founded in 2020 by Regina Mcrae, a…

Read MoreModivcare Honors DAB Transport for Compassionate Service and Community Health Impact
Sickle Cell Treatment Market 2025–2035: R&D, Regulation & Pipeline Trends

Sickle Cell Treatment Market 2025–2035: R&D, Regulation & Pipeline Trends

The “Global Sickle Cell Disease Treatment Market: Focus on Type, End User, and Country-Level Analysis – Analysis and Forecast, 2025-2035″ report has been added to ResearchAndMarkets.com’s offering. The global sickle cell disease treatment market is expected to experience substantial growth, driven by the increasing…

Read MoreSickle Cell Treatment Market 2025–2035: R&D, Regulation & Pipeline Trends
Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

The “Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and Forecast (2021-2031)” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Vaccine market showcased growth at a CAGR of 6.68% during 2021-2024.…

Read MoreCancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

Bradford Health Acquires The Last Resort, Crestone Wellness, and The Chapter House in Texas

Bradford Health Services, a nationally recognized provider of addiction treatment and behavioral healthcare, today announced the acquisition of three Texas-based programs: The Last Resort Recovery Center, Crestone Wellness, and The Chapter House. This marks the second strategic acquisition in less…

Read MoreBradford Health Acquires The Last Resort, Crestone Wellness, and The Chapter House in Texas
Bicycle Therapeutics Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)

Bicycle Therapeutics Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)

Bicycle Therapeutics plc today announced that on July 1, 2025, the Compensation Committee of the company’s Board of Directors granted to eight new employees inducement awards consisting of non-qualified share options to purchase an aggregate of 77,400 ordinary shares. These…

Read MoreBicycle Therapeutics Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)